XOMA Corporation Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Financial Statements Detail (Tables)

Condensed Consolidated Financial Statements Detail (Tables)

9 Months Ended

Sep. 30, 2021

Condensed Consolidated Financial Statements Detail [Abstract]

Accrued and other liabilities consisted of the following (in thousands):


	September 30,		December 31,
	2021		2020
Accrued incentive compensation	$	721	$	71
Accrued legal and accounting fees		429		351
Accrued payroll and other		175		220
Total	$	1,325	$	642

Reconciliation of Numerator and Denominator Used in Calculation of Basic and Diluted Net (Loss) per Share Available to Common Stockholders

The following is a reconciliation of the numerator (net loss) and the denominator (number of shares) used in the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Numerator
Net loss	$	(4,436)	$	(1,077)	$	(14,046)	$	(9,368)
Less: Series A accumulated dividends		(530)		—		(1,591)		—
Less: Series B accumulated dividends		(838)		—		(1,601)		—
Net loss available to common stockholders, basic and diluted	$	(5,804)	$	(1,077)	$	(17,238)	$	(9,368)

Denominator
Weighted average shares used in computing basic and diluted net loss per share available to common stockholders		11,311		11,019		11,279		10,537
Basic and diluted net loss per share available to common stockholders	$	(0.51)	$	(0.10)	$	(1.53)	$	(0.89)

Outstanding Securities Considered Anti-Dilutive

The following table shows the weighted-average shares from outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net loss per share attributable to common stockholders (in thousands):


	Three Months Ended September 30,		Nine Months Ended September 30,
	2021	2020	2021	2020
Convertible preferred stock	5,003	5,003	5,003	5,483
Common stock options	505	931	362	611
Warrants for common stock	4	19	5	21
Total	5,512	5,953	5,370	6,115